Alberto Casellas - 01 Mar 2026 Form 4 Insider Report for Synchrony Financial (SYF)

Signature
/s/ Danielle Do as attorney in fact
Issuer symbol
SYF
Transactions as of
01 Mar 2026
Net transactions value
-$464,095
Form type
4
Filing time
03 Mar 2026, 18:47:18 UTC
Previous filing
19 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Casellas Alberto EVP, CEO--Health & Wellness 777 LONG RIDGE ROAD, C/O CORPORATE SECRETARY, STAMFORD /s/ Danielle Do as attorney in fact 03 Mar 2026 0001763554

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYF Common Stock Award $1,350,064 +19,535 +34% $69.11 76,873 01 Mar 2026 Direct F1
transaction SYF Common Stock Tax liability $839,203 -12,143 -16% $69.11 64,730 01 Mar 2026 Direct F2
transaction SYF Common Stock Sale $974,956 -14,399 -22% $67.71 50,331 02 Mar 2026 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents restricted stock units that will vest in three equal annual installments of 33.33% each, beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial (the "Company") common stock.
F2 Reflects the number of shares of Company common stock withheld by the Company to pay the tax liability of the Reporting Person in connection with the vesting of restricted stock units.
F3 This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on October 27, 2025.

Remarks:

EVP, CEO--Health & Wellness